HealthEquity (NASDAQ:HQY) Lowered to Hold Rating by Wall Street Zen

HealthEquity (NASDAQ:HQY) was downgraded by analysts at Wall Street Zen from a “buy” rating to a “hold” rating in a note issued to investors on Saturday.

Several other research firms have also commented on HQY. UBS Group set a $110.00 target price on HealthEquity in a report on Tuesday, February 17th. BTIG Research decreased their price target on HealthEquity from $130.00 to $110.00 and set a “buy” rating for the company in a report on Tuesday, February 17th. Royal Bank Of Canada lowered their price objective on HealthEquity from $110.00 to $100.00 and set an “outperform” rating on the stock in a research report on Wednesday, March 18th. Barrington Research dropped their price objective on shares of HealthEquity from $125.00 to $110.00 and set an “outperform” rating on the stock in a research note on Wednesday, March 18th. Finally, JPMorgan Chase & Co. cut their target price on shares of HealthEquity from $129.00 to $123.00 and set an “overweight” rating for the company in a report on Wednesday, March 18th. One equities research analyst has rated the stock with a Strong Buy rating, eleven have given a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $110.36.

HealthEquity Trading Down 1.6%

NASDAQ HQY opened at $82.51 on Friday. HealthEquity has a 1 year low of $72.76 and a 1 year high of $116.65. The company has a debt-to-equity ratio of 0.45, a current ratio of 3.27 and a quick ratio of 3.27. The company has a market capitalization of $6.97 billion, a PE ratio of 33.54, a P/E/G ratio of 1.52 and a beta of 0.26. The company has a fifty day moving average of $80.04 and a 200 day moving average of $89.70.

HealthEquity (NASDAQ:HQY) last announced its quarterly earnings results on Tuesday, March 17th. The company reported $0.95 earnings per share for the quarter, topping the consensus estimate of $0.90 by $0.05. The company had revenue of $334.59 million for the quarter, compared to the consensus estimate of $332.48 million. HealthEquity had a return on equity of 13.86% and a net margin of 16.39%.HealthEquity’s quarterly revenue was up 7.3% compared to the same quarter last year. Research analysts forecast that HealthEquity will post 2.32 earnings per share for the current year.

Institutional Trading of HealthEquity

Several institutional investors have recently modified their holdings of HQY. Sivia Capital Partners LLC acquired a new position in shares of HealthEquity during the 2nd quarter worth about $306,000. Cetera Investment Advisers boosted its holdings in HealthEquity by 49.8% in the 2nd quarter. Cetera Investment Advisers now owns 7,881 shares of the company’s stock worth $826,000 after buying an additional 2,621 shares during the last quarter. Legal & General Group Plc increased its stake in HealthEquity by 9.3% during the 2nd quarter. Legal & General Group Plc now owns 163,248 shares of the company’s stock worth $17,102,000 after buying an additional 13,924 shares in the last quarter. Coldstream Capital Management Inc. increased its stake in HealthEquity by 7.3% during the 2nd quarter. Coldstream Capital Management Inc. now owns 2,027 shares of the company’s stock worth $212,000 after buying an additional 138 shares in the last quarter. Finally, Prudential Financial Inc. raised its holdings in shares of HealthEquity by 39.7% during the second quarter. Prudential Financial Inc. now owns 14,155 shares of the company’s stock valued at $1,437,000 after acquiring an additional 4,022 shares during the last quarter. Institutional investors and hedge funds own 99.55% of the company’s stock.

HealthEquity Company Profile

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.